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Exploring the Reliability of the Modified Rankin Scale
Terence J. Quinn, MRCP; Jesse Dawson, MRCP; Matthew R. Walters, MD; Kennedy R. Lees, MD
Background and Purpose—The modified Rankin Scale (mRS) is the most prevalent outcome measure in stroke trials. Use
of the mRS may be hampered by variability in grading. Previous estimates of the properties of the mRS have used
diverse methodologies and may not apply to contemporary trial populations. We used a mock clinical trial design to
explore inter- and intraobserver variability of the mRS.
Methods—Consenting patients with stroke attending for outpatient review had the mRS performed by 2 independent
assessors with pairs of assessors selected from a team of 3 research nurses and 4 stroke physicians. Before formal
assessment, interviewers estimated disability based only on initial patient observation. Each patient was then
randomized to undergo the mRS using standard assessment or a prespecified structured interview. The second
interviewer in the pair reassessed the patient using the same method blinded to the colleague’s score. For each patient
assessed, one rater was randomly assigned to video record their interview. After 3 months, this interviewer reviewed and
regraded their original video assessment.
Results—Across 100 paired assessments, interobserver agreement was moderate (k0.57). Intraobserver variability was
good (k0.72) but less than would be expected from previous literature. Forty-nine assessments were performed using
the structured interview approach with no significant difference between structured and standard mRS. Researchers were
unable to reliably predict mRS from initial limited patient assessment (k0.16).
Conclusions—Despite availability of training and structured interview, there remains substantial interobserver variability
in mRS grades awarded even by experienced researchers. Additional methods to improve mRS reliability are
required. (Stroke. 2009;40:762-766.)
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In stroke trials and in clinical work, robust measures ofpatient outcome are required. The modified Rankin Scale
(mRS)1 is the most prevalent functional outcome measure in
contemporary stroke trials and has been used in several
landmark studies.2,3 The mRS quantifies disability using an
ordinal hierarchical grading from zero (no symptoms) to 5
(severe disability) with some adding a category of mRS 6
(death).
Before any clinical use, assessment scales should be
proven “fit for purpose.” Clinometrics is the methodological
discipline that describes clinical measurement quality. Out-
come scales are traditionally assessed in terms of responsive-
ness, validity, and reliability.4 The original Rankin Scale was
not designed for clinical trial use and, like many other stroke
assessment tools, the mRS became established as a study end
point before any formal clinometric assessment.5
Recent studies have quantified responsiveness of the mRS6
and proven excellent construct and convergent validity of the
scale.7,8 Estimates of mRS reliability have been less favorable
with authors describing substantial interobserver variability.9
This is a concern, because arguably for an instrument that will
be used by many hundreds of raters in large-scale multicenter
clinical trials, reliability is an important property of the scale.
Although all studies to date have confirmed poor reliabil-
ity, there has been heterogeneity in the degree of variability
described.1,10 Differing methodologies used to assess the
mRS may partly explain this. Because we are principally
concerned with variability present in clinical trials, the most
informative analysis of the mRS would be conducted using
current researchers working in a clinical trial setting and
interviewing real stroke survivors. Those few studies that
have attempted this design used only limited numbers of
assessors and/or patients.1,10
In recognition of this potential for variability, techniques to
improve mRS assessment, including structured interview10
and video training,11 have been developed. Studies of the
structured interview approach have yielded conflicting re-
sults,10,12 although again limited numbers of patients and
assessors compromise the generalizability of these reports.
Thus, there are several unanswered questions regarding reli-
ability of mRS assessment. Using a mock clinical trial design,
we set out to study the inter- and intraobserver variability
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when the mRS is applied by experienced and trained study
personnel. We further describe the effect of a structured
interview format on properties of the mRS. Finally, recog-
nizing that initial clinical judgment often influences final
scoring in assessment scales, we described the ability of




We approached sequential patients attending our university hospital
cerebrovascular clinic for their routine poststroke assessment. Clinic
patients have usually been inpatients in the local acute stroke unit
and typically attend for review at 90 days poststroke; however, we
did not set fixed time-related or geographic exclusion criteria. All
patients were considered for inclusion. If cognitive impairment or
language problems precluded satisfactory mRS interview, a proxy
(family member or caregiver) was used. Informed consent was given
by all participants or designated proxy before recruitment and
reconfirmed after the assessment. The local ethics committee ap-
proved the study protocol.
To allow assessment of variability across a representative group,
we involved 7 assessors: 4 stroke physicians and 3 research nurses.
All assessors had been trained and certified in mRS assessment10 and
have considerable experience in mRS application in clinical trials.
We used a stratified assessment technique to test our related
hypotheses (Figure). The selection of mRS assessors, interview
methodology used, and selection for interview recording were all
prespecified using an online randomization program (www.random.
org/integers), and allocation was concealed from interviewers and
patients using an opaque envelope system.
Statistical Analysis
Reliability, or agreement between observers, is traditionally de-
scribed with kappa (k) statistics. The k statistic can be seen as a
measure of agreement, above that expected by chance alone, with
defined standard values of poor (k0.00 to 0.20), fair (k0.21 to
0.40), moderate (k0.41 to 0.60), good (k0.61 to 0.80), and very
good (k0.81 to 1.00) agreement.13
Kappa statistics were chosen for primary analysis because clini-
cians are familiar with the test and because previous studies of mRS
reliability have used similar statistical techniques.
Formal comparisons between kappa statistics are problematic,
particularly if numbers in each group are not comparable. Therefore,
to allow for basic comparative analysis, we also calculated the
number of interviews in which rater pairs agreed exactly on mRS
(expressed as percentage agreement) and compared values using 2
testing. Specific analyses performed for each hypothesis are detailed
in the relevant subsections. All statistics were performed using
Minitab software (Version 14.0; Minitab Inc).
Interobserver Variability for the Traditional
Modified Rankin Scale
For each patient enrolled, 2 assessors allocated from our pool of 7
performed mRS grading. Interviews were performed using a stan-
dard mRS approach or a structured interview with choice of
methodology randomly allocated. Thus, patients had 2 independent
assessments in succession, each using the same interview method-
ology (structured or standard mRS) and blinded to colleagues’
grading. We used the previously validated, questionnaire-style inter-
view for the structured assessments as originally described by
Wilson et al9 with roughly half the assessments conducted using this
structured interview approach.
This initial series of face-to-face paired interviews are further
referred to as “traditional mRS.” We measured interobserver agree-
ment between the paired mRS assessments, first for all interviews
and then with subanalysis to compare structured interview against
standard mRS. We further evaluated duration of the interview for the
structured and standard mRS interview using paired Student t testing.
Intraobserver Variability
One researcher from each interview pair was randomly selected for
video recording. Following advice from the Media Services Depart-
ment, University of Glasgow, audiovisual recording was captured
using a portable digital camera (HDVR-HC1E 1080i digital HD
video camera recorder; Sony) and stored on digital video disc using
readily available image processing software (Windows Movie
Maker; Microsoft).
At a later date, the interviewer who performed the original mRS
assessment viewed this recording and rescored the mRS. We left a
minimum 3-month delay between the interview and assessment of
recording to reduce recall bias. Repeat scoring was performed
independently and raters had no access to their previous scores.
Assessment of intraobserver variability was made comparing all
raters’ original, traditional mRS score with their subsequent video
review score.
Estimating the Modified Rankin Scale
To gauge the added value of formal interview, raters were asked to
grade disability before beginning their formal mRS assessment. This
meant assigning a preliminary mRS using only such information as
would be available in the first few seconds of patient interaction, for
example assessment of patient mobility in the consulting room or
Figure. Schematic diagram of evaluation
process for mRS reliability assessment.
A–B, trained mRS assessors selected
from a pool of 7 research nurses/stroke
physicians. Order of video interview (first
or second in pair) and designation to A or
B were determined by randomization. At
3 months, video-recorded assessments
were reviewed by the original interviewer
and graded again.
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interaction with nurses or caregivers and initial conversation. This
score was recorded and sealed in an opaque envelope. Raters then
conducted and scored the formal mRS assessment. Properties of the
preliminary mRS score were described by comparing these estimates
with the final mRS and by describing variability within the estimated
scores.
Comparison With Previous Literature
To place our results in context, we extracted data from previous
studies of mRS reliability and performed comparative analyses. We
used 2 recently conducted systematic reviews14,15 combined with our
own literature search to select articles that reported on either inter- or
intraobserver reliability of mRS. When possible, we extrapolated
data on variability as measured by kappa statistics and percentage
agreement rates. We compared results from our mRS study with
those published using 2 analysis of proportions.
Results
Of 104 patients approached, 102 consented to mRS interview
and video recording. Of these, 100 video recordings were of
sufficient technical quality to allow repeat grading and were
included in the final analysis. Patients reflected a heteroge-
neous group of stroke subtypes typical of 3-month survivors
(total anterior circulatory stroke, 16; partial anterior circula-
tory stroke, 30; lacunar stroke, 43; posterior circulation stroke,
11; unclassified, 2). Mean age was 69.8 years (SD, 12.9);
mean National Institutes of Health Stroke Scale score at
baseline was 5.5 (SD, 5.2) and median time since the event
was 12 weeks (interquartile range, 6 to 21). Five patients had
problems with communication such that assessment involved
a proxy.
Interobserver Variability for the Traditional
Modified Rankin Scale
Variability in traditional mRS grading was moderate
(k0.57) for the group of 100 paired interviews with least
variability at extremes of mRS (Table 1 ). Exact agreement in
mRS was 67%; this was not significantly different from data
from previously published studies (P0.073; Table 2).
Of the traditional mRS assessments, 49 used a structured
interview approach. There was no difference in spread of
disability as graded on mRS between the 2 groups (P0.699
on 2 testing). Use of the structured interview did not
decrease variability (P0.295; Tables 1 and 2). Mean dura-
tion of mRS assessment was 4.9 minutes (SD, 2.4). There was
a significant difference between duration of structured (5.6
minutes; SD, 2.5) and unstructured (4.2 minutes; SD, 2.1)
interviews (P0.003).
Intraobserver Variability for the Modified
Rankin Scale
One patient withdrew consent for video assessment after
recording, leaving 99 video assessments that could be re-
viewed and scored by the original mRS assessors. Intraob-
server reliability was good for the group (k0.72; 77%
complete agreement; Table 3); this differs significantly from
other published studies of mRS intraobserver variability
(P0.0001). Intraobserver variability for individual raters
was calculated; percentage agreement was similar for most
raters (Rater 1: 86%; Rater 2: 89%; Rater 3: 75%; Rater 4:
40%; Rater 5: 63%; Rater 6: 100%; Rater 7: 91%). Differ-
ences in numbers of patients assessed by each rater precludes
formal statistical comparison.
Estimating the Modified Rankin Scale
A convenience sample of preliminary mRS interviews was
included. Because estimation of mRS is dependent on confi-
dence in basic mRS administration, we included only the
latter 40 mRS interviews in this analysis to eliminate any
potential training effect. Agreement between estimated and
final mRS was 38% and reliability was poor (k0.16). The
Table 1. Group Reliability of Traditional mRS Assessment*
mRS










Overall k N/A 0.57
Structured interview k N/A 0.5
Standard interview k N/A 0.64
*To quantify spread of disability, the average no. of patients scoring at each
mRS grade is presented; these numbers were derived from the total no. of
scores at a particular grade divided by the total no. of assessors.
N/A indicates not applicable.
Table 2. Interobserver Variability in mRS Comparing Our
Study With Other Published Data*
mRS Variability
(% Agreement)
Quinn—total mRS k0.57 (67%)
Standard mRS k0.64 (72%)
Structured mRS k0.50 (63%)
Newcommon—standard mRS k0.72 (N/A)
Structured mRS k0.38 (N/A)
Wilson ’05—standard mRS k0.25 (43%)
Structured mRS k0.74 (81%)
Wilson ’02—standard mRS k0.44 (57%)
Structured mRS k0.70 (78%)
Wolfe—standard mRS kw0.90 (80%)
Van Sweiten—standard mRS k0.56 (65%)
*Variability is described using kappa (k) and percentage exact agreement;
there were no significant differences in percent agreement between studies.
N/A indicates not available.
Table 3. Intraobserver Variability in mRS Comparing Our





Wilson ’05 k0.83 (92%)†
*Variability is described using kappa (k) and percentage exact agreement.
†Average across structured and standard interview approaches.
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mean estimated mRS was 1. (SD, 1.1); mean final mRS was
1.6 (SD, 0.9). Comparing estimated scores between the paired
assessors, there was again poor agreement in 30% and
significant variability (k0.38).
Discussion
Using a mock clinical trial design, we assessed reliability of
the mRS across a large number of patients. We have demon-
strated substantial interobserver and intraobserver variability
in mRS assessment. Furthermore, we have found that a
structured interview approach does not significantly improve
reliability and we confirmed that researchers are poor at
estimating mRS if they do not conduct a formal interview.
Despite considerable experience in clinical use of the mRS,
our team of clinicians and nurses show only moderate
reliability in mRS grading. This interobserver variability is in
keeping with previous published estimates.1,10 With increas-
ing use of the mRS as a trial end point16 and ready availability
of specific training resources,11 some improvement in mRS
reliability was expected. Diverse study methodologies pre-
clude any more definitive comment on these differences;
suffice to say that problems with reliability represent an
ongoing limitation of standard mRS as a trial end point. In the
absence of a pretraining “control,” our findings do not allow
us to comment on usefulness of the training resource or on
any training effects associated with increasing experience of
real-life mRS administration.
Variability was most apparent for mRS grades 1 to 4. This
is of particular importance for clinical trial end point analysis,
in which mRS outcomes are often dichotomized around these
middle grades. Misclassification of end points increases the
likelihood of Type II error and decreases statistical power.
The potential impact of mRS variability on clinical trial
results has yet to be modeled, but we must assume that poor
reliability will influence final results. Real-life examples of
trials compromised by variability in end point classification
are well recognized17 and may be particularly relevant in the
field of acute stroke, in which some have argued that recent
unexpected neutral trial outcomes have stemmed from under-
powering in trial design.18
Quantification of intraobserver reliability for clinical scales
is challenging and if methodology is poor, there is potential
for bias. Measuring test–retest variability over a short time
period will be biased by observer recall of previous grading;
delaying the second grading can allow for patient improve-
ment or disease progression. Previous published studies have
not accounted for these sources of bias in their design and, as
such, the negligible interobserver variability they report for
mRS should be questioned.8,9 Our use of videos provides a
more rigorous assessment of intraobserver reliability and may
explain the significantly higher variability demonstrated.
Because trialists are unlikely to be performing serial mRS
over short time periods, it could be argued that proving
intraobserver variability of the mRS is of little clinical
relevance. However, we describe our findings here as further
evidence of the imperfections of the standard mRS as an end
point assessment tool.
Use of a structured interview approach to mRS assessment
did not reduce interobserver variability in our cohort. The
authors of one questionnaire-style structured interview previ-
ously reported significant improvements in reliability9; how-
ever, other groups have failed to replicate these findings12
and, at present, the structured interview is infrequently used
by stroke trialists. Our results show that for experienced
raters, fully trained in mRS administration, use of a structured
approach may have little to add. The difference in interview
duration between the traditional and structured approach with
no improvements in reliability suggests that certain compo-
nents of the structured interview may be redundant.
Our final analysis described efficacy of initial limited
disability assessment as a predictor of final mRS grading.
Such an approach is not without precedent. It is recognized
that for many scales, raters may not perform a comprehensive
assessment; rather, they will estimate final grading based on
initial basic review and “clinical intuition.”19 For disability
scales, including the mRS, full assessment has been reduced
to a limited number of key questions while preserving
clinometric properties.20 The mRS is heavily weighted toward
locomotor independence and so we hypothesized that distinc-
tion between higher and lower grades may be possible simply
by observing the patient entering the clinic. We have shown
that experienced raters are poor at predicting the final mRS
from initial assessment and that a formal interview is still
required to grade disability.
A particular strength of our study was the mock clinical
trial design simulating those situations in which the mRS is
likely to be used. We adopted an inclusive policy, studying a
large representative cohort of stroke survivors. We deliber-
ately selected a panel of assessors from different clinical
backgrounds because previous work has suggested that pro-
fession and training may impact on reliability of outcomes
assessment.21 Limited numbers of patients and use of asses-
sors from similar backgrounds have compromised previous
studies of mRS reliability.1,10 The use of video recording to
assess intraobserver variability was successful with minimal
expenditure in terms of money and training. Other centers
have also demonstrated efficacy of remote video-based mRS
assessment.22 These results suggest feasibility of remote
video-based mRS assessment as a further aid to improve
reliability.
Although number of patients included in our analysis is
greater than in many previous studies of mRS, we still had
relatively few assessors and all were from the same depart-
ment. Ideally, we would have involved multiple centers in our
analysis. In this regard, our study is complemented by recent
work describing moderate to good overall reliability on a
5-patient mRS assessment exercise across a large cohort of
international trialists.21
We deliberately chose to test a number of related hypoth-
eses using a predefined structured design, thus deriving
substantial data from a single clinical encounter. However,
we prespecified our several hypotheses to limit the risk of
drawing false conclusions as a result of multiplicity. Our
results do not negate the potential benefit of training and we
would encourage trialists to continue to use specific mRS
training resources. Future trials designed to improve mRS
assessment are planned; pending these results, our current
data encourage caution in use and interpretation of the
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standard mRS. Because measures to date have not substan-
tially improved mRS interobserver variability, a possible
option for future trials is to limit the number of observers.
Remote adjudication panel assessment of laboratory and
imaging end points is commonplace in contemporary multi-
center trials and perhaps should now become routine for
assessment of functional outcomes.
In conclusion, we have shown that despite increasing
familiarity with the mRS and availability of specific training
packages, there remains substantial variability in the mRS
that could compromise clinical trial results. Further measures
to improve mRS reliability are urgently required.
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